Mandy Cranney, NP Registered Nurse - Medical-Surgical Medicare: Medicare Enrolled Practice Location: 27 Mill St, Waldoboro, ME 04572 Phone: 207-832-2300 |
Jennie K Mcneil, FNP-BC, PMHNP-BC Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13 Bowden Rd, Waldoboro, ME 04572 Phone: 207-542-7820 |
Laurence Victor Hills, RN Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 841 Old Route 1, Waldoboro, ME 04572 Phone: 207-832-1096 |
News Archive
Intermittent androgen deprivation (IAD) is commonly used in the treatment of CaP, which theoretically may delay the development of hormone resistance.
Malignant hyperthermia (MH) is a potentially life-threatening inherited disorder of muscle. Patients who are at risk for MH usually have no outward signs of muscle problems. However, when exposed to certain commonly used general anesthetics they may develop very high body temperature, increased heart rate and muscle breakdown. If not recognized and treated promptly MH may be fatal.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring, and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, jointly announce today CE Mark certification and the European launch of the BMEYE ccNexfin—the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology
› Verified 9 days ago